On the pharmacology and toxicology of neutrophils

Neuroendocrinology Letters

Volumn 27, Issue SUPPL. 2, 2006, Pages 148-151

  Nosál, Rado ^a   Drábiková, Katarina ^a   Jančinová, Viera ^a   Mačičková, Tatiana ^a   Pečivová, Jana ^a   Holomáňová, Dagmar ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b National Transfusion Service   (Slovakia)

Author keywords

Extra and intracellular chemiluminescence; H1 antihistamines; Myeloperoxidase; Neutrophils; Oxidative burst; Superoxide

Indexed keywords

CYTOCHROME C; DIANISIDINE; DITHIADEN; HISTAMINE; LORATADINE; LUMINOL; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; CELL LEVEL; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME RELEASE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NEUTROPHIL; RESPIRATORY BURST; SPECTROPHOTOMETRY;

EID: 34047226089     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Babior BM. Phagocytes and oxidative stress. Am J Med. 2000; 109(1):33-44.
2. 1-receptor effects of antihistamines. Clin Exp Allergy. 1999; 29(Suppl.3):39-48.
3. Costa D, Moutinho L, Costa Lima JLF, Fernandez E. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull. 2006; 29(8):1659-70.
4. 1-antagonist loratadine. Inflamm Res. 2006; 55(Suppl 1):S19-20.
5. 1-antagonist dithiaden in human PMN leukocytes. Free Rad Res. 2002; 36(9):975-80.
6. Hampton MB, Kettle AJ, Winterborn CC. Inside the neutrophil phagozome: oxidants, myeloperoxidase and bacterial killing. Bood. 1998; 92(9):3007-17.
7. Hojo M, Hamasaki Y, Fujita I, Koga H, Matsumoto S, Miyazaki S. Effect of anti-allergy drugs on fMet-Leu-Phe - stimulated superoxide generation in human neutrophils. Ann Allergy. 1994; 73(1):21-6.
8. Jančinová V, Drábiková K, Nosál' R, Májeková M, Račková L, Holomáňová D. Antiradical effects of antihistamines in human blood. Structure-activity relationship. Inflamm Res. 2006; 55(Suppl.1): S85-6.
9. Jančinová V, Drábiková K, Nosál' R, Račková L, Májeková M, Holomáňová D. The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils. Redox Rep. 2006; 11(3):110-5.
10. Kindzelski AL. Clark AJ, Espinosa J, Maeda N, Aratani Y, Romero R, Petty HR. Myeloperoxidase accumulates at the neutrophil surface and enhances cell metabolism and oxidant release during pregnancy. Eur J Immunol. 2006; 36(4):1619-28.
11. Lilius EME, Nuutila JTJ. Particle-induced myeloperoxidase release in serially diluted whole blood quantifies the number and the phagocytic activity of blood neutrophils and opsonization capacity of plasma. Luminescence. 2006; 21(3):148-58.
12. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005; 25(1):29-38.
13. Nosál' R. Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugs. Cardiovasc Hematol Agents Med Chem. 2006; 4(3):237-61.
14. 1-antihistamines. Inflamm Res. 2005; 54(Suppl.1):S19-20.
15. Nosál' R, Jančinová V. Cationic amphiphilic drugs and platelet phospholipase A2. Thromb Res. 2002; 105(3):339-45.
16. Pečivová J, Mačičková T, Nosál' R, Fabryová V. Stobadine-modulated human neutrophil functional responsiveness: Effect on particular and soluble stimulation. Meth Find Exp Clin Pharmacol. 2004; 26(6):395-8.
17. Saito T, Takahashi H, Doken H, Koyama H, Aratani Y. Phorbol myristate acetate induces neutrophil death through activation of P38 nitrogen-activated protein kinase that requires endogenous reactive oxygen species other than HOCI. Biosci Biotechnol Biochem. 2005; 69(11):2207-12.
18. 1-receptor blocking drugs on metabolic activation of neutrophils. J Pharmacobiodyn. 1991; 14(6):87-93.